New

Next Generation Cancer Diagnostics Market

2021

Next Generation Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (QPCR and Multiplexing, Benchtop Sequencers, Lab-on-a-chip, Next Generation Sequencing, Protein Microarrays, DNA Microarrays); Application (Biomarker Development, Proteomic Analysis, CTC Analysis, Genetic Analysis, Epigenetic Analysis); Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Others); Function (Cancer Screening, Therapeutic Monitoring, Prognosis Diagnostics, Risk Analysis, Companion Diagnostics) and Geography

| Report Code: TIPRE00006920 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Next Generation Cancer Diagnostics Market 2028 By Technology, Application, Cancer Type, Function and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Next-generation cancer diagnostics are helping in the early detection and prevention of cancer. Researchers are constantly working on developing novel cancer diagnostic tools as well as improving existing ones. Many market companies are working together to create new cancer biomarkers and assays, which is fueling market growth. Cancer diagnostics assist in early detection of cancers for better treatment options. Next generation cancer diagnostics will assist in detection of disease with full precision and at lower costs.

MARKET SCOPE

The "Global Next Generation Cancer Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the next generation cancer diagnostics market with detailed market segmentation by technology, application, cancer type and function. The report provides key statistics on the market status of the leading next generation cancer diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on technology the market is segmented as, qPCR and multiplexing, benchtop sequencers, lab-on-a-chip, next generation sequencing, protein microarrays, DNA microarrays.
  •   Based on application the market is segmented as, biomarker development, proteomic analysis, CTC analysis, genetic analysis, and epigenetic analysis.
  •   Based on cancer type the market is segmented as, lung cancer, colorectal cancer, breast cancer, prostate cancer, and others.
  •   Based on function the market is segmented as, cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis, and companion diagnostics.

MARKET DYNAMICS
Drivers:

  •   Rising prevalences of cancers and different kind of malignancies.
  •   Growing awareness among people for early detection of disease is also expected to spur the market growth.
  •   Extensive R&D efforts to develop more advanced and precise diagnostics for cancer is likely to fuel the market growth.
  •   Rising automation and next level technologies in diagnostic laboratories.

Restraints:

  •   However, involvement of high cost in diagnostic imaging systems and stringent regulatory framework are likely to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The next generation cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the next generation cancer diagnostics market in these regions.

IMPACT OF COVID-19 ON NEXT GENERATION CANCER DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the next generation cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from next generation cancer diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for next generation cancer diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the next generation cancer diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Agilent Technologies, Inc
  •   Illumina, Inc
  •   PerkinElmer Inc
  •   F. Hoffmann-La Roche Ltd
  •   GENERAL ELECTRIC
  •   OPKO Health, Inc.
  •   QIAGEN
  •   Thermo Fisher Scientific Inc.
  •   Abbott
  •   Cepheid
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Next Generation Cancer Diagnostics Market - By Technology
1.3.2 Next Generation Cancer Diagnostics Market - By Application
1.3.3 Next Generation Cancer Diagnostics Market - By Cancer Type
1.3.4 Next Generation Cancer Diagnostics Market - By Function
1.3.5 Next Generation Cancer Diagnostics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NEXT GENERATION CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. NEXT GENERATION CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NEXT GENERATION CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEXT GENERATION CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEXT GENERATION CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. QPCR AND MULTIPLEXING
7.3.1. Overview
7.3.2. qPCR and Multiplexing Market Forecast and Analysis
7.4. BENCHTOP SEQUENCERS
7.4.1. Overview
7.4.2. Benchtop Sequencers Market Forecast and Analysis
7.5. LAB-ON-A-CHIP
7.5.1. Overview
7.5.2. Lab-on-a-chip Market Forecast and Analysis
7.6. NEXT GENERATION SEQUENCING
7.6.1. Overview
7.6.2. Next Generation Sequencing Market Forecast and Analysis
7.7. PROTEIN MICROARRAYS
7.7.1. Overview
7.7.2. Protein Microarrays Market Forecast and Analysis
7.8. DNA MICROARRAYS
7.8.1. Overview
7.8.2. DNA Microarrays Market Forecast and Analysis
8. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BIOMARKER DEVELOPMENT
8.3.1. Overview
8.3.2. Biomarker Development Market Forecast and Analysis
8.4. PROTEOMIC ANALYSIS
8.4.1. Overview
8.4.2. Proteomic Analysis Market Forecast and Analysis
8.5. CTC ANALYSIS
8.5.1. Overview
8.5.2. CTC Analysis Market Forecast and Analysis
8.6. GENETIC ANALYSIS
8.6.1. Overview
8.6.2. Genetic Analysis Market Forecast and Analysis
8.7. EPIGENETIC ANALYSIS
8.7.1. Overview
8.7.2. Epigenetic Analysis Market Forecast and Analysis
9. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LUNG CANCER
9.3.1. Overview
9.3.2. Lung Cancer Market Forecast and Analysis
9.4. COLORECTAL CANCER
9.4.1. Overview
9.4.2. Colorectal Cancer Market Forecast and Analysis
9.5. BREAST CANCER
9.5.1. Overview
9.5.2. Breast Cancer Market Forecast and Analysis
9.6. PROSTATE CANCER
9.6.1. Overview
9.6.2. Prostate Cancer Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - FUNCTION
10.1. OVERVIEW
10.2. FUNCTION MARKET FORECASTS AND ANALYSIS
10.3. CANCER SCREENING
10.3.1. Overview
10.3.2. Cancer Screening Market Forecast and Analysis
10.4. THERAPEUTIC MONITORING
10.4.1. Overview
10.4.2. Therapeutic Monitoring Market Forecast and Analysis
10.5. PROGNOSIS DIAGNOSTICS
10.5.1. Overview
10.5.2. Prognosis Diagnostics Market Forecast and Analysis
10.6. RISK ANALYSIS
10.6.1. Overview
10.6.2. Risk Analysis Market Forecast and Analysis
10.7. COMPANION DIAGNOSTICS
10.7.1. Overview
10.7.2. Companion Diagnostics Market Forecast and Analysis

11. NEXT GENERATION CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Next Generation Cancer Diagnostics Market Overview
11.1.2 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.1.3 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.1.4 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.1.5 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.1.6 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.1.7 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Next Generation Cancer Diagnostics Market
11.1.7.1.1 United States Next Generation Cancer Diagnostics Market by Technology
11.1.7.1.2 United States Next Generation Cancer Diagnostics Market by Application
11.1.7.1.3 United States Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.1.4 United States Next Generation Cancer Diagnostics Market by Function
11.1.7.2 Canada Next Generation Cancer Diagnostics Market
11.1.7.2.1 Canada Next Generation Cancer Diagnostics Market by Technology
11.1.7.2.2 Canada Next Generation Cancer Diagnostics Market by Application
11.1.7.2.3 Canada Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.2.4 Canada Next Generation Cancer Diagnostics Market by Function
11.1.7.3 Mexico Next Generation Cancer Diagnostics Market
11.1.7.3.1 Mexico Next Generation Cancer Diagnostics Market by Technology
11.1.7.3.2 Mexico Next Generation Cancer Diagnostics Market by Application
11.1.7.3.3 Mexico Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.3.4 Mexico Next Generation Cancer Diagnostics Market by Function
11.2. EUROPE
11.2.1 Europe Next Generation Cancer Diagnostics Market Overview
11.2.2 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.2.3 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.2.4 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.2.5 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.2.6 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.2.7 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Next Generation Cancer Diagnostics Market
11.2.7.1.1 Germany Next Generation Cancer Diagnostics Market by Technology
11.2.7.1.2 Germany Next Generation Cancer Diagnostics Market by Application
11.2.7.1.3 Germany Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.1.4 Germany Next Generation Cancer Diagnostics Market by Function
11.2.7.2 France Next Generation Cancer Diagnostics Market
11.2.7.2.1 France Next Generation Cancer Diagnostics Market by Technology
11.2.7.2.2 France Next Generation Cancer Diagnostics Market by Application
11.2.7.2.3 France Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.2.4 France Next Generation Cancer Diagnostics Market by Function
11.2.7.3 Italy Next Generation Cancer Diagnostics Market
11.2.7.3.1 Italy Next Generation Cancer Diagnostics Market by Technology
11.2.7.3.2 Italy Next Generation Cancer Diagnostics Market by Application
11.2.7.3.3 Italy Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.3.4 Italy Next Generation Cancer Diagnostics Market by Function
11.2.7.4 Spain Next Generation Cancer Diagnostics Market
11.2.7.4.1 Spain Next Generation Cancer Diagnostics Market by Technology
11.2.7.4.2 Spain Next Generation Cancer Diagnostics Market by Application
11.2.7.4.3 Spain Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.4.4 Spain Next Generation Cancer Diagnostics Market by Function
11.2.7.5 United Kingdom Next Generation Cancer Diagnostics Market
11.2.7.5.1 United Kingdom Next Generation Cancer Diagnostics Market by Technology
11.2.7.5.2 United Kingdom Next Generation Cancer Diagnostics Market by Application
11.2.7.5.3 United Kingdom Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.5.4 United Kingdom Next Generation Cancer Diagnostics Market by Function
11.2.7.6 Rest of Europe Next Generation Cancer Diagnostics Market
11.2.7.6.1 Rest of Europe Next Generation Cancer Diagnostics Market by Technology
11.2.7.6.2 Rest of Europe Next Generation Cancer Diagnostics Market by Application
11.2.7.6.3 Rest of Europe Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.6.4 Rest of Europe Next Generation Cancer Diagnostics Market by Function
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Next Generation Cancer Diagnostics Market Overview
11.3.2 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.3.3 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.3.4 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.3.6 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.3.7 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Next Generation Cancer Diagnostics Market
11.3.7.1.1 Australia Next Generation Cancer Diagnostics Market by Technology
11.3.7.1.2 Australia Next Generation Cancer Diagnostics Market by Application
11.3.7.1.3 Australia Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.1.4 Australia Next Generation Cancer Diagnostics Market by Function
11.3.7.2 China Next Generation Cancer Diagnostics Market
11.3.7.2.1 China Next Generation Cancer Diagnostics Market by Technology
11.3.7.2.2 China Next Generation Cancer Diagnostics Market by Application
11.3.7.2.3 China Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.2.4 China Next Generation Cancer Diagnostics Market by Function
11.3.7.3 India Next Generation Cancer Diagnostics Market
11.3.7.3.1 India Next Generation Cancer Diagnostics Market by Technology
11.3.7.3.2 India Next Generation Cancer Diagnostics Market by Application
11.3.7.3.3 India Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.3.4 India Next Generation Cancer Diagnostics Market by Function
11.3.7.4 Japan Next Generation Cancer Diagnostics Market
11.3.7.4.1 Japan Next Generation Cancer Diagnostics Market by Technology
11.3.7.4.2 Japan Next Generation Cancer Diagnostics Market by Application
11.3.7.4.3 Japan Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.4.4 Japan Next Generation Cancer Diagnostics Market by Function
11.3.7.5 South Korea Next Generation Cancer Diagnostics Market
11.3.7.5.1 South Korea Next Generation Cancer Diagnostics Market by Technology
11.3.7.5.2 South Korea Next Generation Cancer Diagnostics Market by Application
11.3.7.5.3 South Korea Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.5.4 South Korea Next Generation Cancer Diagnostics Market by Function
11.3.7.6 Rest of Asia-Pacific Next Generation Cancer Diagnostics Market
11.3.7.6.1 Rest of Asia-Pacific Next Generation Cancer Diagnostics Market by Technology
11.3.7.6.2 Rest of Asia-Pacific Next Generation Cancer Diagnostics Market by Application
11.3.7.6.3 Rest of Asia-Pacific Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.6.4 Rest of Asia-Pacific Next Generation Cancer Diagnostics Market by Function
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Next Generation Cancer Diagnostics Market Overview
11.4.2 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.4.3 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.4.4 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.4.6 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.4.7 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Next Generation Cancer Diagnostics Market
11.4.7.1.1 South Africa Next Generation Cancer Diagnostics Market by Technology
11.4.7.1.2 South Africa Next Generation Cancer Diagnostics Market by Application
11.4.7.1.3 South Africa Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.1.4 South Africa Next Generation Cancer Diagnostics Market by Function
11.4.7.2 Saudi Arabia Next Generation Cancer Diagnostics Market
11.4.7.2.1 Saudi Arabia Next Generation Cancer Diagnostics Market by Technology
11.4.7.2.2 Saudi Arabia Next Generation Cancer Diagnostics Market by Application
11.4.7.2.3 Saudi Arabia Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.2.4 Saudi Arabia Next Generation Cancer Diagnostics Market by Function
11.4.7.3 U.A.E Next Generation Cancer Diagnostics Market
11.4.7.3.1 U.A.E Next Generation Cancer Diagnostics Market by Technology
11.4.7.3.2 U.A.E Next Generation Cancer Diagnostics Market by Application
11.4.7.3.3 U.A.E Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.3.4 U.A.E Next Generation Cancer Diagnostics Market by Function
11.4.7.4 Rest of Middle East and Africa Next Generation Cancer Diagnostics Market
11.4.7.4.1 Rest of Middle East and Africa Next Generation Cancer Diagnostics Market by Technology
11.4.7.4.2 Rest of Middle East and Africa Next Generation Cancer Diagnostics Market by Application
11.4.7.4.3 Rest of Middle East and Africa Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.4.4 Rest of Middle East and Africa Next Generation Cancer Diagnostics Market by Function
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Next Generation Cancer Diagnostics Market Overview
11.5.2 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.5.3 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.5.4 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.5.5 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.5.6 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.5.7 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Next Generation Cancer Diagnostics Market
11.5.7.1.1 Brazil Next Generation Cancer Diagnostics Market by Technology
11.5.7.1.2 Brazil Next Generation Cancer Diagnostics Market by Application
11.5.7.1.3 Brazil Next Generation Cancer Diagnostics Market by Cancer Type
11.5.7.1.4 Brazil Next Generation Cancer Diagnostics Market by Function
11.5.7.2 Argentina Next Generation Cancer Diagnostics Market
11.5.7.2.1 Argentina Next Generation Cancer Diagnostics Market by Technology
11.5.7.2.2 Argentina Next Generation Cancer Diagnostics Market by Application
11.5.7.2.3 Argentina Next Generation Cancer Diagnostics Market by Cancer Type
11.5.7.2.4 Argentina Next Generation Cancer Diagnostics Market by Function
11.5.7.3 Rest of South and Central America Next Generation Cancer Diagnostics Market
11.5.7.3.1 Rest of South and Central America Next Generation Cancer Diagnostics Market by Technology
11.5.7.3.2 Rest of South and Central America Next Generation Cancer Diagnostics Market by Application
11.5.7.3.3 Rest of South and Central America Next Generation Cancer Diagnostics Market by Cancer Type
11.5.7.3.4 Rest of South and Central America Next Generation Cancer Diagnostics Market by Function

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. NEXT GENERATION CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. AGILENT TECHNOLOGIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ILLUMINA, INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PERKINELMER INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GENERAL ELECTRIC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. OPKO HEALTH, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. QIAGEN
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. THERMO FISHER SCIENTIFIC INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABBOTT
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CEPHEID
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Agilent Technologies, Inc
- Illumina, Inc
- PerkinElmer Inc
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC
- OPKO Health, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Abbott
- Cepheid
- Novartis AG
- Myriad Genetics, Inc
- Genomic Testing Cooperative
- Almac Group
- Sysmex Corporation
TIPRE00006920
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.